Taiwanese schools and research institutions aren't the only places to acquire new drugs with development potential; we could also acquire licenses to the results of preliminary clinical trials conducted abroad and continue to develop these drugs.
這些值得開發的新藥來源，不一定只有國內的學研單位，還可以把國外已經做好的初期臨床試驗成果 license（取得授權）進來，我們再往下走、增加它的價值。